Researchers have pinpointed the cause of depression to dysfunctions in just two types of brain cells, offering new insights into the biological basis of the disorder. This breakthrough could pave the way for more targeted treatments for depression, one of the most prevalent mental health conditions worldwide.
New research reveals depression may stem from dysfunction in two specific brain cell types, offering promising directions for targeted treatments.
In a significant advancement in mental health research, scientists have discovered that depression may originate primarily from abnormalities in just two types of brain cells. The study, published on October 13, 2025, provides new understanding into the biological mechanisms underlying depression, which affects millions globally.
Researchers from leading neuroscience institutes conducted extensive analyses of brain tissue and cellular activity, identifying that disruptions in specific neuronal and glial cell populations are central to the development of depressive symptoms. These findings contrast earlier theories that suggested depression was caused by broad chemical imbalances or widespread brain region dysfunction.
“Our research indicates that targeted dysfunction in these two types of brain cells can explain many of the core features of depression,” said Dr. Anjali Mehta, the study’s lead author and a neuroscientist at the National Institute of Mental Health. “This narrows the focus for potential treatments and could lead to more effective, personalized therapies.”
The two brain cell types highlighted are a specific subset of inhibitory neurons and a form of astrocytes, a type of glial cell involved in supporting neurons and maintaining brain homeostasis. The impaired function of these cells appears to disrupt neural circuitry critical for mood regulation and cognitive processes.
Depression has long been considered a complex disorder influenced by genetic, environmental, and neurological factors. Traditional antidepressants aim to balance neurotransmitters such as serotonin but often have limited efficacy and delayed onset of action. This new cellular-level insight opens avenues for therapies that directly restore the function of affected brain cell populations.
Experts unaffiliated with the study praise the research as a major step forward. Dr. Emily Grant, a psychiatrist at the University of Cambridge, commented, “Understanding the specific cellular disruptions in depression helps us rethink how we approach diagnosis and treatment. This could revolutionize psychiatric care in the coming years.”
The research team plans to continue exploring how these brain cell types contribute to depression’s varying symptoms and severity. Additionally, they aim to develop experimental treatments targeting these cells to improve clinical outcomes.
This discovery offers hope that addressing the root cellular causes of depression might lead to faster and more sustained relief for patients, reducing the global burden of this debilitating condition.
For more details, the full study is available at the Times of India: https://timesofindia.indiatimes.com/science/the-real-cause-of-depression-may-lie-in-just-two-brain-cell-types-scientists-say/articleshow/124517986.cms
